Santen Pharmaceutical
4536.TTSE PRIMEPharmaceutical
Filed as SANTEN PHARMACEUTICAL CO., LTD. (2022-06–2026-06)
In English · 3
Tue, Oct 27 · JST1 filing
10:41MATERIALSanten Pharmaceutical · Change in major shareholderMon, Oct 26 · JST1 filing
15:285% STAKESanten Pharmaceutical · Silchester International Investors LLP · 9.23% → 10.25%+1.02ppTue, Oct 8 · JST1 filing
16:48MATERIALSanten Pharmaceutical · Change in parent company or specified subsidiaryAll EDINET filings · 93
| Filed | Document | Source |
|---|---|---|
| 2017-08-04 | Quarterly report | S100B03M |
| 2017-06-23 | Annual report | S100AJZW |
| 2017-02-10 | Quarterly report | S1009MMA |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 21 financial reports not structured yet.
Not structured yet
| 2021-12-31 | quarterly | original indexed | S100NH24 |
| 2021-09-30 | quarterly | original indexed | S100MRMS |
| 2021-06-30 | quarterly | original indexed | S100M77A |
| 2021-03-31 | annual | original indexed | S100LRJK |
| 2020-12-31 | quarterly | original indexed | S100KNUG |
| 2020-09-30 | quarterly | original indexed | S100K3HT |
| 2020-06-30 | quarterly | original indexed | S100JF5R |
| 2020-03-31 | annual | original indexed | S100IX5J |
| 2019-12-31 | quarterly | original indexed | S100HWLV |
| 2019-09-30 | quarterly | original indexed | S100H9FZ |
| 2019-06-30 | quarterly | original indexed | S100GL7Q |
| 2019-03-31 | annual | original indexed | S100G69C |
| 2018-12-31 | quarterly | original indexed | S100F4BQ |
| 2018-09-30 | quarterly | original indexed | S100EHNG |
| 2018-06-30 | quarterly | original indexed | S100DREL |
| 2018-03-31 | annual | original indexed | S100DDCH |
| 2017-12-31 | quarterly | pending download | S100CBBL |
| 2017-09-30 | quarterly | pending download | S100BMKZ |
| 2017-06-30 | quarterly | pending download | S100B03M |
| 2017-03-31 | annual | pending download | S100AJZW |
| 2016-12-31 | quarterly | pending download | S1009MMA |